Tigatuzumab (CS-1008)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 23:37, 23 February 2021 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2)

Retrieved from "https://hemonc.org/w/index.php?title=Tigatuzumab_(CS-1008)&oldid=47283"